Article
miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy
2021-09-09
Abstract excerpt
<title>Abstract</title> <p>Background Accumulating evidences reveal that aberrant microRNAs (miRNAs) expression can affect the development of chemotherapy drug resistance by modulating the expression of relevant target proteins. Emerging evidences have demonstrated that miR-133a participates in tumorigenesis of various cancers. However, whether miR-133a is associated with cisplatin resistance in ovarian cancer r...
Topics
Open a Topic to create a Post that cites this publication.
- Autophagy in Disease and Therapy
- Cancer-related molecular mechanisms research
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Genomics, phytochemicals, and oxidative stress
- Hippo pathway signaling and YAP/TAZ
- Histone Deacetylase Inhibitors Research
- MicroRNA in disease regulation
- RNA modifications and cancer
Identifiers and source
- Literature Corpus work
- e54b117b-23c3-5771-a240-233e0f35b940
- DOI
- 10.21203/rs.3.rs-861069/v1
